Merck Sharp and Dohme Australia Pty Ltd

Regulatory activities for this sponsor.

4 result(s) found, displaying 1 to 4

AusPAR: Bezlotoxumab

24 September 2018

Australian Public Assessment Report (AusPAR)

Australian Public Assessment Report for Bezlotoxumab
AusPAR: Suvorexant

1 June 2018

Australian Public Assessment Report (AusPAR)

Australian Public Assessment Report for Suvorexant
AusPAR: Grazoprevir / Elbasvir

15 May 2017

Australian Public Assessment Report (AusPAR)

Australian Public Assessment Report for Grazoprevir / Elbasvir
AusPAR: Suvorexant

11 March 2015

Australian Public Assessment Report (AusPAR)

Australian Public Assessment Report for Suvorexant